Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases
Henry Ordutowski, Francesco Dal Dosso, Wout De Wispelaere, Charlotte Van Tricht, Séverine Vermeire, Nick Geukens, Ann Gils, Dragana Spasić, Jeroen Lammertyn
Topics & Concepts
Point of careTherapeutic drug monitoringWhole bloodMedicineDrugPoint-of-care testingMicrofluidicsAdalimumabAnalyteLab-on-a-chipBiomedical engineeringPharmacologyNanotechnologyImmunologyChemistryChromatographyMaterials sciencePathologyRheumatoid arthritisMicrofluidic and Bio-sensing TechnologiesBiosensors and Analytical DetectionMicrofluidic and Capillary Electrophoresis Applications